A truncated, highly bioavailable form of IGF-1 that is estimated to be up to 10 times more potent at the tissue level than standard IGF-1. It has a very short half-life and acts locally near the injection site rather than systemically.
What is this used for?
How do you take it?
These are typical doses from research and real prescriptions — not a recommendation for you specifically. Your provider will adjust based on your body, your goals, and your health history.
How well researched is this?
Very Early Research Status
Published preclinical research demonstrates significantly higher tissue-level potency than IGF-1 LR3. No human clinical trials have been conducted.
Legal status
Expected to return to legal compounding status in 2026, meaning licensed doctors can prescribe it and regulated pharmacies can prepare it.
2026 reclassification status updates coming soon.
Purity
Purity measures how clean and accurate the compound is. Higher purity means fewer contaminants and more reliable dosing.
HPLC Purity Tested
Always require a Certificate of Analysis (CoA) from a US-based compounding pharmacy.
Common questions
Ready to start?
Consult with a licensed provider to determine the right protocol for your goals.

